OBJECTIVE -We have previously suggested using the paired values of fasting plasma glucose (FPG) and HbA 1c to identify potential diabetic subjects. In this article, we followed up on 208 nondiabetic subjects and examined their rates of progression to diabetes. We analyzed their likelihood of becoming diabetic according to their baseline FPG and HbA 1c concentrations. -Between 1988 and 1995, 2,877 Chinese subjects with risk factors for diabetes underwent screening. Of these, 2,250 had FPG Ͻ7.8 mmol/l and 2-h plasma glucose (PG) Ͻ11.1 mmol/l. Of these 2,250 subjects, 265 were randomly recruited for an annual oral glucose tolerance test (OGTT) until they progressed to develop diabetes. Of those 265 subjects, 57 had baseline FPG Ն7.0 mmol/l and were excluded from the present analysis. Hence, the progression of glucose tolerance in 208 subjects who were nondiabetic according to the new American Diabetes Association diagnostic criteria (FPG Ͻ7.0 mmol/l and 2-h PG Ͻ11.1 mmol/l) was examined RESULTS -Of the 208 nondiabetic subjects, 26 (12.5%) were men and 182 (87.5%) were women. After a mean follow-up of 1.60 ± 1.16 years (range 1-7, median 1), 44 (21.2%) progressed to develop diabetes and 164 (78.8%) remained nondiabetic. Those who were diabetic at the end of the study had a high likelihood ratio (LR) of 9.3 to have baseline FPG Ն6.1 mmol/l and baseline HbA 1c Ն6.1%. This was compared with a low LR of 0.6-1.1 in diabetic subjects who had either FPG Ͻ6.1 mmol/l or HbA 1c Ͻ6.1% or both at baseline. The crude rate of progression to diabetes was more than five times higher (44.1 vs. 8.1%) in those whose baseline FPG was Ն6.1 mmol/l and baseline HbA 1c was Ն6.1% compared with those whose baseline FPG was Ͻ6.1 mmol/l and baseline HbA 1c was Ͻ6.1%.
B
ecause the performance of an oral glucose tolerance test (OGTT) is time consuming, laborious, and poorly reproducible (1-3), the American Diabetes Association (ADA) recently recommended moving away from the OGTT to using fasting plasma glucose (FPG) as a diagnostic criterion (4) . Furthermore, the diagnostic FPG value of 7.8 mmol/l as recommended by the World Health Organization (WHO) in 1985 has often been criticized as being too high in many racial groups (5) (6) (7) (8) . In Hong Kong Chinese, the FPG value corresponding to the 2-h plasma glucose (PG) of 11.1 mmol/l was 5.7 mmol/l (8) . For these reasons, the ADA has recommended an FPG diagnostic criterion of Ն7.0 mmol/l for diabetes instead of 7.8 mmol/l (4) .
Although the use of FPG is simpler and more reproducible (9, 10) , the omission of the 2-h PG will miss a proportion of diabetic subjects who have normal FPG but elevated 2-h PG (Ն11.1 mmol/l) (11) . We have suggested using the paired values of FPG and HbA 1c to identify potential diabetic subjects (12) . Only those with high FPG (6.1-6.9 mmol/l) and high HbA 1c (Ն6.1%) required an OGTT to confirm diabetes. With use of this approach, Ͼ80% of OGTTs could be saved (12) . In this article, we followed up on 208 nondiabetic subjects and examined their rates of progression to diabetes. We analyzed their likelihood of becoming diabetic according to their baseline FPG and HbA 1c concentrations.
RESEARCH DESIGN AND METHODS

Patients and methods
The Diabetes and Endocrine Center of the Prince of Wales Hospital encourages subjects with risk factors to undergo an OGTT to screen for diabetes. The risk factors for screening included family history of diabetes, history of gestational diabetes, history of impaired glucose tolerance (IGT), or obesity (with BMI Ն25 kg/m 2 ). Between 1988 and 1995, 2,877 subjects underwent screening. Of these, 2,250 had FPG Ͻ7.8 mmol/l and 2-h PG Ͻ11.1 mmol/l. Of these 2,250 subjects, 265 were randomly (every 1 in 10, consecutively) recruited for a regular yearly OGTT until they had progressed to develop diabetes. Of the 265 subjects, 57 had baseline FPG Ն7.0 mmol/l and were excluded from the present analysis. Hence, the progression of glucose tolerance in 208 subjects who were nondiabetic according to the new ADA diagnostic criteria (FPG Ͻ7.0 mmol/l and 2-h PG Ͻ11.1 mmol/l) was examined (4) .
On the study day, the subjects attended in a fasting state without taking any medication. Their demographic data, medical history, family history of diabetes, and smoking habit were recorded. Height and weight (measured to the nearest 0.1 kg) were measured with the subject wearing light clothing and without shoes. BMI was calculated as the weight (kilograms) divided by the square of the height (meters). After the subject was sitting for at least 5 min, blood pressure (BP) was measured in his or her right arm by the same research nurse using a standard mercury sphygmomanometer. The Korotkoff sound V was taken as the diastolic BP. The mean value of two readings measured 1 min apart was used. All subjects underwent a 75-g OGTT for diagnosis of diabetes and IGT using the ADA criteria (4). Smoking was not allowed during the test. HbA 1c and fasting and 2-h PG concentrations were measured during the OGTT. Diabetes was diagnosed if FPG was Ն7.0 mmol/l or 2-h PG was Ն11.1 mmol/l. IGT was diagnosed if FPG was Ͻ7.0 mmol/l and 2-h PG was Ն7.8 but Ͻ11.1 mmol/l. Subjects with FPG Ͻ7.0 mmol/l and 2-h PG Ͻ7.8 mmol/l had normal glucose tolerance.
PG was measured by a glucose oxidase method (Diagnostic Chemicals reagent kit). Both the intra-and interassay coefficients of variation (CVs) for glucose were 2% at 6.6 mmol/l. HbA 1c was measured by an automated ion-exchange chromatographic method (Bio-Rad, Hercules, CA [manufacturer' s reference range 5.1-6.4%]). The intra-and interassay CVs for HbA 1c were Յ3.1% at values Ͻ8.5%.
Statistical analysis
Statistical analysis was performed using the SPSS (version 6.0) software on an IBMcompatible computer. All results are expressed as means ± SD. The likelihood ratio (LR) (13) was calculated to estimate the odds of having glucose intolerance using the ADA criterion in subjects categorized according to the screening values of FPG (Ͻ6 mmol/l) and HbA 1c (Ͻ6%). Kaplan-Meier analysis was performed to study the progression to diabetes in subjects with various FPG and HbA 1c concentrations. A P value Ͻ0.05 (two-tailed) was considered to be significant. The 208 subjects were categorized into four groups based on their baseline FPG (Ն6.1 or Ͻ6.1 mmol/l) and HbA 1c (Ն6.1 or Ͻ6.1%) concentrations. These values were selected on the basis of our previous analyses (12, 14) using FPG of 6.1 mmol/l (the cutoff for impaired fasting glucose) and HbA 1c of 6.1% (the optimal value corresponded to 2-h PG Ն11.1 mmol/l using receiver operating characteristic analysis in our previous study) as the cutoff. The paired values of FPG Ն6.1 mmol/l and HbA 1c Ն6.1% had a high LR of 17.2 to occur in diabetic subjects as compared with nondiabetic subjects (14) .
RESULTS -
Their outcomes based on the results of the OGTT are summarized in Table 2 . Those who were diabetic at the end of the study had a high LR of 9.3 to have baseline FPG Ն6.1 mmol/l and baseline HbA 1c Ն6.1%. This finding was compared with a low LR of 0.6-1.1 in diabetic subjects who had either FPG Ͻ6.1 mmol/l or HbA 1c Ͻ6.1% or both at baseline. The crude rate of progression to diabetes was more than five times higher (44.1 vs. 8.1%) in those whose baseline FPG was Ն6.1 mmol/l and baseline HbA 1c was Ն6.1% compared with those whose baseline FPG was Ͻ6.1 mmol/l and baseline HbA 1c was Ͻ6.1%. The corresponding 50% "survival time" was 2.27 years (1.38-3.17) and 5.85 years Fasting plasma glucose and HbA 1c predict diabetes (5.21-6.49), respectively (log-rank test: P Ͻ 0.001) (Fig. 1) .
CONCLUSIONS -
The new ADA diagnostic criterion using FPG is much simpler in application in the community (4). However, if the 2-h PG is omitted, fewer people will be diagnosed with diabetes. Harris et al. (15) reported that in the U.S. population, of the 6.4% undiagnosed diabetic subjects according to the 1985 WHO criteria, 4.0% were diagnosed on the basis of the 2-h PG (i.e., FPG Ͻ7.8 mmol/l and 2-h PG Ն11.1 mmol/l), 2.2% had both FPG Ն7.8 mmol/l and 2-h PG Ն11.1 mmol/l, and only 0.2% were diagnosed on the basis of FPG (i.e., FPG Ն7.8 mmol/l and 2-h PG Ͻ11.1 mmol/l). If a lower cutoff value of 7.0 mmol/l was used, a high proportion (3.0% of the total 6.4%) of diabetic subjects would still be missed (i.e., FPG Ͻ7.0 mmol/l and 2-h PG Ն11.1 mmol/l). Similarly, in Hong Kong Chinese, our population-based epidemiological study showed that 70-80% of our diabetic subjects were diagnosed on the basis of the 2-h PG (i.e., FPG Ͻ7.8 mmol/l and 2-h PG Ն11.1 mmol/l) (7). In selected Chinese subjects with known risk factors for glucose intolerance who underwent screening by OGTT, 40% had FPG Ͻ7.0 mmol/l and 2-h PG Ն11.1 mmol/l, whereas 60%
had FPG Ͻ7.8 mmol/l and 2-h PG Ն11.1 mmol/l (12) . Hence, despite the use of the new diagnostic criteria, 40% of diabetic subjects would still have been missed if only FPG was used. In fact, in Chinese, Ͻ10% of diabetic subjects were diagnosed solely on the basis of FPG (i.e., FPG Ն7.0 mmol/l and 2-h PG Ͻ11.1 mmol/l) (12) . In light of the data presented above, the WHO has therefore continued to recommend the use of the OGTT in subjects who have impaired fasting glycemia (FPG 6.1-6.9 mmol/l) to exclude diabetes or IGT (16) . The key question is how to screen for these high-risk subjects for confirmatory OGTT. The screening test needs to be simple, reproducible, and easily available as well as sensitive and specific. Combining the sensitivity of FPG and the specificity of HbA 1c , we have reported the predictive value of this paired value for the diagnosis of diabetic subjects. With use of the 2-h postglucose loading PG Ն11.1 mmol/l (as the reference test) (12, 14) , the paired values of FPG Ն6.1 mmol/l and HbA 1c Ն6.1% had a 13-to 17-fold increased likelihood to occur in diabetic subjects (depending on whether the 1985 WHO or 1997 ADA criteria were used) than nondiabetic subjects. This finding was compared with a likelihood of only 0.16 for subjects with FPG Ͻ6.1 mmol/l and HbA 1c Ͻ6.1% (14) . When such an approach is used, only those with FPG Ն6.1 mmol/l but Ͻ7.8 mmol/l (or FPG Ն6.1 but Ͻ7.0 mmol/l if the 1997 ADA criteria were used) and an HbA 1c Ն6.1% required an OGTT to confirm diabetes, thereby saving 88-93% of all OGTTs (14) .
The present study involved subjects at high risk for diabetes. Hence, a relatively high proportion of 21.2% progressed to develop diabetes after a mean follow-up of 1.6 years. This finding gave a crude rate of progression to diabetes of 13.3% per year. Accordingly, we have previously shown that 11.5% of Hong Kong Chinese with IGT progress to diabetes each year (17) . This conversion rate is one of the highest reported among different ethnic populations, although it is still lower than the rate of 15.7% per year reported by Pan et al. (18) in the Da Qing Study, which involved the Chinese population in northern China.
In Caucasians with or without risk factors for diabetes, it is not clear whether the use of paired values of FPG and HbA 1c can predict progression to diabetes as accurately as in the present study. However, we have previously shown that this screening approach also performs well in Hong Kong Chinese without risk factors for diabetes who were recruited in a population-based study (19) . On the other hand, a recent study in the U.S. by Davidson et al. (20) reported that ϳ60% of subjects being diagnosed as diabetic based on FPG alone had normal HbA 1c levels. They suggested that diabetes should not be diagnosed in those with FPG concentrations Ͻ7.8 mmol/l, unless excess glycosylation (HbA 1c above a certain cutoff) is evident (20) . Wiener and Roberts (21) also reported a significant number of individual discrepancies (false positives and negatives) in using FPG (Ն7 mmol/l) alone to diagnose diabetes, and they suggested that more diagnostic confidence could be placed in a positive HbA 1c (Ͼ6.2%).
In this study, we have shown that nondiabetic Chinese subjects with risk factors for glucose intolerance who had FPG Ն6.1 mmol/l and HbA 1c Ն6.1% had a crude rate of progression to diabetes of 44.1% per year. This result was 5.4 times higher in comparison to those with FPG Ͻ6.1 mmol/l and HbA 1c Ͻ6.1% who had a crude rate of progression of 8.1% per year. These high conversion rates might be related to the high-risk characteristics of these subjects (17) . These findings complement our previous reports regarding the use of high FPG and high HbA 1c in predicting progression to diabetes. In this respect, a recent report has also shown that an HbA 1c value of 2 SD above the normal mean was also highly predictive of diabetes (22) .
In conclusion, for subjects with risk factors for glucose intolerance, the use of paired values of FPG and HbA 1c helped to identify potential diabetic subjects. Those with FPG Ն6.1 mmol/l and HbA 1c Ն6.1% had a rate of progression to diabetes more than five times higher than those with FPG Ͻ6.1 mmol/l and HbA 1c Ͻ6.1% after a mean follow-up of 1.6 years. In agreement with the 1998 WHO recommendation, those with an FPG Ն6.1 mmol/l but Ͻ7.0 mmol/l, especially if their HbA 1c is Ն6.1%, should undergo an OGTT to confirm diabetes. Other subjects at risk for diabetes (such as those who are Ͼ45 years of age) with an FPG Ͻ6.1 mmol/l and/or an HbA 1c Ͻ6.1% should have regular screening. Whether the use of a paired value of FPG and HbA 1c as a screening method will be superior to others needs further prospective study.
